Literature DB >> 7991124

Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies.

J L Laplanche1, N Delasnerie-Lauprêtre, J P Brandel, J Chatelain, P Beaudry, A Alpérovitch, J M Launay.   

Abstract

Human prion diseases are characterized by the accumulation in the brain of an abnormal form of the prion protein. Prion protein polymorphisms seem to play a key role in the pathogenesis of these diseases, probably by enhancing the amyloidogenic properties of the protein. We performed prion protein gene (PRNP) coding sequence analysis in 57 French subjects with Creutzfeldt-Jakob disease (CJD) and found a mutation of the PRNP coding sequence in nine subjects (15.8%); the mutation corresponded with a known family history of CJD in only three of these subjects. In 41 definite and probable cases without known PRNP mutations, codon 129 genotyping revealed an excess of the homozygous 129Met/Met genotype corresponding to a 3.4-fold increased risk of developing CJD when compared with the two other genotypes. We also found that the 129Val/Val genotype, which mainly governs susceptibility to iatrogenic CJD, does not seem to predispose to sporadic CJD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991124     DOI: 10.1212/wnl.44.12.2347

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

2.  Genotype frequencies at codon 129 of the prion protein gene in Brazil: Implications in susceptibility to variant Creutzfeldt-Jakob disease compared to European and Asian populations.

Authors:  Erich Vinicius de Paula; Marcelo Addas-Carvalho; Devanira Souza Paixao Costa; Sara Terezinha Olalla Saad; Simone Cristina Olenscki Gilli
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Analysis of PRNP gene codon 129 polymorphism in the Greek population.

Authors:  Angelica A Saetta; Nikolaos V Michalopoulos; George Malamis; Polyanthi I Papanastasiou; Niki Mazmanian; Maria Karlou; Anastasios Kouzoupis; Penelope Korkolopoulou; Efstratios Patsouris
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  Conformational pH dependence of intermediate states during oligomerization of the human prion protein.

Authors:  Remo Gerber; Abdessamad Tahiri-Alaoui; P J Hore; William James
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

5.  Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.

Authors:  Susanne DiSalvo; Tricia R Serio
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

6.  Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.

Authors:  Nicolas Privat; Etienne Levavasseur; Serfildan Yildirim; Samia Hannaoui; Jean-Philippe Brandel; Jean-Louis Laplanche; Vincent Béringue; Danielle Seilhean; Stéphane Haïk
Journal:  J Biol Chem       Date:  2017-08-15       Impact factor: 5.157

Review 7.  Prion diseases.

Authors:  Edward McKintosh; Sarah J Tabrizi; John Collinge
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  The M129V polymorphism of codon 129 in the prion gene (PRNP) in the Danish population.

Authors:  Henrik Dyrbye; Helle Broholm; Morten Hanefeld Dziegiel; Henning Laursen
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

9.  Polymorphisms of the prion protein gene (PRNP) in a Korean population.

Authors:  Byung-Hoon Jeong; Jae-Hwan Nam; Yun-Jung Lee; Kyung-Hee Lee; Myoung-Kuk Jang; Richard I Carp; Ho-Dong Lee; Young-Ran Ju; Sangmee Ahn Jo; Keun-Yong Park; Yong-Sun Kim
Journal:  J Hum Genet       Date:  2004-05-18       Impact factor: 3.172

Review 10.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.